My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Heartcore Enterprises, Inc. - Common Stock (NQ:HTCR)

0.8052 -0.0448 (-5.27%)
Streaming Delayed Price Updated: 11:15 AM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Heartcore Enterprises, Inc. - Common Stock

Gateway Group Announces Final Lineup of 60+ Companies Across AI, FinTech, Cleantech, and Other Growth Sectors Presenting in San Francisco Sept. 3–4
Gateway Conference expected to draw 300+ institutional investors for company presentations and exclusive one-on-one meetings 
From Gateway Group
Via GlobeNewswire
HeartCore's Go IPO Client, SBC Medical Group, Begins Trading on the Nasdaq Stock Exchange
From HeartCore Enterprises, Inc
Via ACN Newswire
This Japanese Tech Company Just Boosted Its Capabilities As It Expands Into The US Market
Learn More about HeartCore Enterprises, Inc. by gaining access to the latest research report 
Via TheNewswire.com
TechMediaBreaks – HeartCore Enterprises, Inc. (NASDAQ: HTCR) Enters Agreements for up to $27 Million to Fund M&A and Maintain Nasdaq Listing
Via Investor Brand Network
Sidoti Events, LLC's Virtual May Micro-Cap Conference
Via ACCESS Newswire
HeartCore Enterprises Inc. (NASDAQ: HTCR) Featured in Coverage of the 37th Annual ROTH Conference
Via Investor Brand Network
Topics Initial Public Offering
HeartCore to Present at the 2024 Gateway Conference on September 4 at 10:30 a.m. Pacific Time
From HeartCore Enterprises Inc.
Via GlobeNewswire
Does This Acquisition Represent A Core Change At The Heart Of The SaaS Industry?
Learn More about HeartCore Enterprises, Inc. by gaining access to the latest research report 
Via TheNewswire.com
Traders News Source Editor Mark Roberts Interviews Sumitaka Kanno CEO and Founder at HeartCore Inc.
NEW YORK, NY / ACCESSWIRE / July 1, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid cap publicly traded companies recently issued a... 
From Traders News Source
Via AccessWire
Central Nervous System (CNS) Therapeutics Global Market Expected to Reach $154 Billion By 2027
Palm Beach, FL – June 9, 2022 – FinancialNewsMedia.com News Commentary – The central nervous system (CNS) consists of the brain and spinal cord and brain and nervous system problems are more common and... 
Via FinancialNewsMedia
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.